Newman Dignan & Sheerar Inc’s Medicenna Therapeutics Corp. Common Shares MDNA Stock Holding History

Newman Dignan & Sheerar Inc’s Portfolio MDNA Stock Details MDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-12,915	Closed	-$3.94K	–	192
2023 Q4	$3.94K	Buy	+12,915	New	+$3.45K	﹤0.01%	179
2023 Q3	–	Sell	-12,915	Closed	-$6.22K	–	188
2023 Q2	$6.22K	Hold	12,915	–	–	﹤0.01%	187
2023 Q1	$8.13K	Hold	12,915	–	–	﹤0.01%	194
2022 Q4	$5.92K	Hold	12,915	–	–	﹤0.01%	191
2022 Q3	$11	Buy	+12,915	New	+$14.6K	﹤0.01%	182
2022 Q2	–	Sell	-12,915	Closed	-$17	–	209
2022 Q1	$17	Sell	12,915 -1,000	-7%	-$1.55K	﹤0.01%	195
2021 Q4	$23K	Buy	13,915 +1,000	+8%	+$2.07K	0.01%	199
2021 Q3	$36K	Buy	+12,915	New	+$32K	0.01%	189

Newman Dignan & Sheerar Inc's MDNA Position: Q1 2024 in Review

Newman Dignan & Sheerar Inc sold out of Medicenna Therapeutics Corp. Common Shares (MDNA) in Q1 2024, closing a stake of 12,915 shares — an estimated $3.94K sold.

Newman Dignan & Sheerar Inc first reported a position in MDNA in Q3 2021 and held it in 8 quarters. The position peaked at $36K in Q3 2021. 0 funds tracked by Wall St. Rank hold MDNA as of Q1 2024.

Newman Dignan & Sheerar Inc reported no remaining Medicenna Therapeutics Corp. Common Shares position as of Q1 2024 after selling out during the quarter.
Newman Dignan & Sheerar Inc sold 12,915 Medicenna Therapeutics Corp. Common Shares shares in Q1 2024, an estimated $3.94K.
Newman Dignan & Sheerar Inc first reported a position in Medicenna Therapeutics Corp. Common Shares in Q3 2021 and held it in 8 quarters.
Newman Dignan & Sheerar Inc's Medicenna Therapeutics Corp. Common Shares position peaked at $36K in Q3 2021.
0 funds tracked by Wall St. Rank held Medicenna Therapeutics Corp. Common Shares as of Q1 2024.

Based on Newman Dignan & Sheerar Inc's 13F filing for Q1 2024, filed 29 Apr 2024.